Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Hayashibara to Develop Alzheimer's Disease Vaccine
March 13, 2006
- Explanatory Meeting on JapicCTI
March 13, 2006
- ＜JCROA Seminar＞Collaborative Int'l Trials Remain Risky: Dr Iwasaki of EFPIA
March 13, 2006
- GENERICS NEWS IN BRIEF
March 13, 2006
- R&D NEWS IN BRIEF
March 13, 2006
- Eisai Aims at \1 Tril. Sales in FY2011
March 13, 2006
- SELF-MEDICATION NEWS IN BRIEF
March 13, 2006
- Bill to Amend PAL to Be Presented to Diet on March 10
March 6, 2006
- DSP's Ambisome to Be Approved for Import
March 6, 2006
- Astellas' Vesicare Recommended for Approval: CDFS
March 6, 2006
- Korosho to Move to Eliminate Provisional Delivery of Drugs
March 6, 2006
- REGULATORY NEWS IN BRIEF
March 6, 2006
- Bayer, Onyx Initiate PIII Lung Cancer Study Using Nexavar
March 6, 2006
- SEMIANAR
March 6, 2006
- Switch to Aromasin Maintains QOL of Breast Cancer Patients: IES Study
March 6, 2006
- Pfizer Japan to Appoint New President & CEO
March 6, 2006
- R&D NEWS IN BRIEF
March 6, 2006
- GSK to Participate in Vaccine Business in Japan
March 6, 2006
- MEDICAL DEVICE NEWS IN BRIEF
March 6, 2006
- MPC, Lequio Pharma License Zione to Yuhan of South Korea
March 6, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…